|
1. Common drug may limit cancer treatment's efficacy: Study Full story
2. Novartis drug fails late-stage trial for artery disease Full story
3. Impossible to solve this with manpower alone: How systems are rethinking Rx access, here.
4. New norovirus strain may be shifting seasonal patterns: 6 CDC notes Full story
5. RFK Jr. sued over COVID guidance change: 10 details Full story
6. Nearly 1 in 3 leaders say poor AI integration is holding them back. What's easing adoption: here.
7. FDA approves Regeneron drug to treat multiple myeloma Full story
8. HHS' new vaccine panel backs RSV shot, rejects thimerosal in flu vaccines Full story
Becker's Learning Opportunities
9. $31B lost to claim denials each year. The playbook for smarter workflows here.
10. LifeBridge is making both short-term stability + long-term growth work. See how: here.
11. Rush got 12x ROI from better OR access. See how they did it — here.
|
.png)
